National Healthcare
109 hedge funds and large institutions have $398M invested in National Healthcare in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 48 increasing their positions, 32 reducing their positions, and 7 closing their positions.
375% more call options, than puts
Call options by funds: $5.04M | Put options by funds: $1.06M
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
50% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 32
6% more funds holding
Funds holding: 103 → 109 (+6)
0.69% more ownership
Funds ownership: 36.65% → 37.34% (+0.69%)
0% more capital invested
Capital invested by funds: $397M → $398M (+$1.44M)
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$4.5M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.21M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.01M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.64M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.55M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.46M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.78M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$967K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$489K |
| 5 |
QI
Quotient Investors
New York
|
-$386K |
NHC Hedge Fund Activity: Q2 2017 in Review
109 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in National Healthcare (NHC) for Q2 2017, worth a combined $398M — up 0.36% from $397M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new NHC positions and 7 closed out — a net gain of 6 holders — while 48 added to existing stakes and 32 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $4.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $7.46M.
- 109 institutional investors held National Healthcare (NHC) as of Q2 2017, up from 103 in Q1 2017.
- Funds reported $398M of National Healthcare stock for Q2 2017, up 0.36% quarter-over-quarter.
- 13 funds opened new National Healthcare positions in Q2 2017 and 7 closed out, a net change of +6 holders.
- The largest National Healthcare buyer in Q2 2017 was Renaissance Technologies, an estimated $4.5M added.
- The largest National Healthcare seller in Q2 2017 was T. Rowe Price Associates, an estimated $7.46M sold.
Based on aggregated 13F filings for Q2 2017.